Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
38
38 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BerobenatidePF-08653944, MET097Phase 319 trials
Pfizer · Obesity, Overweight and/or Obesity, Overweight
- GiredestrantRO7197597, GDC-9545Phase 316 trials
Roche (Genentech) · Early Breast Cancer, Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
- PF-08634404SSGJ-707Phase 312 trials
Pfizer · Non-Small Cell Lung Cancer, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung (NSCLC)
- AtirmociclibPF-07220060Phase 39 trials
Pfizer · Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer
- PF-07275315tilrekimigPhase 38 trials
Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease
- RSVpreFRESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, PF-06928316Phase 38 trials
Pfizer · Respiratory Syncytial Virus (RSV), Lower Respiratory Tract Illness, Adult
- PG4Phase 35 trials
Pfizer · Pneumococcal Disease
- DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization
- VLA15PF-07307405Phase 34 trials
Pfizer · Lyme Disease, Lyme Borreliosis
- CasdatifanAB521Phase 33 trials
Arcus Biosciences, Inc. · Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma (RCC)
- Leuprorelin acetateLeuprolide Open Label, DKF-MA102Phase 33 trials
Pfizer · Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
- MevrometostatPF-06821497Phase 33 trials
Pfizer · Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer
- RSVpreF VaccinePhase 33 trials
Pfizer · Respiratory Syncytial Virus, Respiratory Syncytial Virus (RSV)
- Sigvotatug VedotinSGN-B6A, PF-08046047Phase 33 trials
Pfizer · Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
- C.difficile vaccinepreviously studiedPhase 32 trials
Pfizer · Clostridoides Difficile Associated Disease
- CMP 001VidutolimodPhase 32 trials
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- ibuzatrelvirPF-07817883Phase 32 trials
Pfizer · COVID-19 SARS-CoV-2 Infection, COVID-19 Infection
- PF-07248144Phase 32 trials
Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- PF-08046054SGN-PDL1VPhase 32 trials
Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma
- su vaccineRZVPhase 32 trials
GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)
- PF-06823859Phase 31 trial
Pfizer · Myositis
- PF-06838435fidanacogene elaparvovecPhase 31 trial
Pfizer · Hemophilia B
- PF04518600Phase 31 trial
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- ponsegromabPhase 31 trial
Pfizer · Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
- Prevenar 20Phase 31 trial
Pfizer · Healthy
- SasanlimabPF-06801591Phase 31 trial
Pfizer · Non-muscle Invasive Bladder Cancer
- UtomilumabPhase 31 trial
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- PF-07104091ovarian, SCLCPhase 22 trials
Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer
- MET233Phase 21 trial
Pfizer · Obesity and Obesity-related Medical Conditions
- PCV1515-valent pneumococcal conjugate vaccinePhase 21 trial
Pfizer · Pneumococcal Disease
- PF-0704091Phase 21 trial
Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
- PF-07264660Phase 21 trial
Pfizer · Atopic Dermatitis
- PF-07328948Phase 21 trial
Pfizer · Heart Failure
- PF-07868489Phase 21 trial
Pfizer · Pulmonary Arterial Hypertension
- PF-07976016Phase 21 trial
Pfizer · Obesity
- PF-08049820Phase 21 trial
Pfizer · Atopic Dermatitis, Eczema, Atopic
- PF-08154225Phase 21 trial
Pfizer · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis
- PF-08653945Phase 21 trial
Pfizer · Overweight, Obesity, Overweight and/or Obesity
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.